GlassScriptPhysician profile
Beverly S Everitt
NPI 1023124492
$12,202.51
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,250 · 2022: $2,396 · 2023: $6,544 · 2024: $13.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,600 · Food and Beverage: $1,839 · Gift: $59.40 · Travel and Lodging: $58.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,600.00 |
| Food and Beverage | $1,838.61 |
| Gift | $59.40 |
| Travel and Lodging | $58.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $5,151.85 | 2021-2023 | V-Go, Afrezza |
| Lilly USA, LLC | $1,366.43 | 2021-2023 | Mounjaro, Trulicity, Humulin |
| Zealand Pharma US, INC. | $842.60 | 2021-2022 | |
| Novo Nordisk INC | $590.21 | 2021-2023 | Rybelsus, Ozempic, Saxenda |
| Insulet Corporation | $516.76 | 2021-2023 | Omnipod |
| Medtronic, INC. | $512.43 | 2021-2023 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $413.02 | 2021-2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $371.23 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.14 | 2022-2023 | Jardiance |
| Dexcom, INC. | $266.73 | 2021-2023 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $212.05 | 2021-2023 | |
| Amgen INC. | $180.44 | 2021-2023 | Prolia, Evenity |
| Abbvie INC. | $157.04 | 2021-2024 | |
| Abbott Laboratories | $154.52 | 2021-2023 | Freestyle Libre 3 |
| Corcept Therapeutics | $131.25 | 2022-2023 | Korlym |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $125.01 | 2021-2023 | Unithroid |
| Astrazeneca Pharmaceuticals LP | $114.97 | 2021 | |
| Lifescan, INC. | $108.38 | 2022-2023 | |
| Amarin Pharma, INC. | $99.23 | 2021 | |
| Pfizer INC. | $87.63 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $83.09 | 2021-2023 | Steglatro, Steglujan |
| Esperion Therapeutics, INC. | $54.43 | 2021-2022 | |
| Antares Pharma, INC. | $45.24 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Ultragenyx Pharmaceutical INC. | $42.70 | 2022-2023 | |
| Clarus Therapeutics INC. | $29.42 | 2021 | |
| Intuity Medical INC | $26.08 | 2022 | |
| Becton, Dickinson and Company | $23.11 | 2022 | |
| Ibsa Pharma INC. | $21.83 | 2021 | |
| Janssen Pharmaceuticals, INC | $21.81 | 2021 | |
| Nevro Corp. | $21.37 | 2022 | |
| Horizon Therapeutics Plc | $20.93 | 2022 | |
| Radius Health, INC. | $20.38 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.32 | 2023 | |
| Endo Pharmaceuticals INC. | $17.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Everitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.